1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Michigan >
  6. Shionogi Acquires Tetra Therapeutics

M&A Deal Summary

Shionogi Acquires Tetra Therapeutics

On May 26, 2020, Shionogi acquired life science company Tetra Therapeutics

Acquisition Highlights
  • This is Shionogi’s 1st transaction in the Life Science sector.
  • This is Shionogi’s 1st transaction in the United States.
  • This is Shionogi’s 1st transaction in Michigan.

M&A Deal Summary
Date 2020-05-26
Target Tetra Therapeutics
Sector Life Science
Buyer(s) Shionogi
Deal Type Add-on Acquisition

Target

Tetra Therapeutics

Grand Rapids, Michigan, United States
Tetra Therapeutics is a clinical-stage biotechnology company developing a portfolio of therapeutic products that will bring clarity of thought to people suffering from Fragile X syndrome, Alzheimer's disease, traumatic brain injury, and other brain disorders. Tetra Therapeutics is based in Grand Rapids, Michigan.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Shionogi

Osaka, Japan
Category Company
Founded 1878
Sector Life Science
Employees4,955
Revenue 438.3B JPY (2025)
DESCRIPTION

Shionogi is a pharmaceutical company that researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices. Shionogi was founded in 1878 and is based in Osaka, Japan.

DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 3 of 3
State: Michigan M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2020 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-08-01 C&O Pharmaceutical Technology Holdings

Tsim Sha Tsui, China

C&O is an integrated pharmaceutical group in China. Its activities span research & development, manufacturing, and marketing and distribution of C&O and third party brand products.

Buy $185M
Mergr

Solution for

Product

Company

Legal